Riggs Asset Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1
Closed -$33 373
2025
Q2
$33 Hold
1
﹤0.01% 914
2025
Q1
$27 Hold
1
﹤0.01% 634
2024
Q4
$30 Hold
1
﹤0.01% 640
2024
Q3
$27 Hold
1
﹤0.01% 632
2024
Q2
$28 Buy
+1
New +$27 ﹤0.01% 650
2018
Q4
Sell
-62,073
Closed -$2.39M 241
2018
Q3
$2.39M Sell
62,073
-524
-0.8% -$19.3K 1.17% 26
2018
Q2
$2.2M Buy
62,597
+40
+0.1% +$1.4K 0.97% 31
2018
Q1
$2.08M Buy
62,557
+1,080
+2% +$36.8K 0.86% 35
2017
Q4
$2.04M Buy
+61,477
New +$2.04M 0.82% 37

Other funds holding FFTY

Riggs Asset Management's FFTY Position: Q3 2025 in Review

Riggs Asset Management sold out of CapForce IBD 50 ETF (FFTY) in Q3 2025, closing a stake of 1 share — an estimated $33 sold.

Riggs Asset Management first reported a position in FFTY in Q4 2017 and held it in 9 quarters. The position peaked at $2.39M in Q3 2018. 40 funds tracked by Wall St. Rank hold FFTY as of Q3 2025.

  • Riggs Asset Management reported no remaining CapForce IBD 50 ETF position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 1 CapForce IBD 50 ETF share in Q3 2025, an estimated $33.
  • Riggs Asset Management first reported a position in CapForce IBD 50 ETF in Q4 2017 and held it in 9 quarters.
  • Riggs Asset Management's CapForce IBD 50 ETF position peaked at $2.39M in Q3 2018.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.